Safety and Activity of the Immune Modulator HE2000 on the Incidence of Tuberculosis and Other Opportunistic Infections in AIDS Patients
暂无分享,去创建一个
Armando Garsd | A. Garsd | Dwight R. Stickney | Zoja Noveljic | Daniel A. Destiche | James M. Frincke | J. Frincke | D. Stickney | D. Destiche | Z. Noveljic
[1] G. Rook,et al. 16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. , 2005, The Journal of infectious diseases.
[2] D. Freilich,et al. 16alpha-bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. , 2000, The American journal of tropical medicine and hygiene.
[3] Wayne B. Nelson,et al. Recurrent Events Data Analysis for Product Repairs, Disease Recurrences, and Other Applications , 2002 .
[4] P. Fitzgerald-Bocarsly,et al. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. , 2001, Clinical immunology.
[5] A. Garsd,et al. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000). , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] William Q. Meeker,et al. Recurrent Events Data Analysis for Product Repairs, Disease Recurrences, and Other Applications , 2003, Technometrics.
[7] Zhiliang Ying,et al. Semiparametric regression for the mean and rate functions of recurrent events , 2000 .
[8] P. Arese,et al. 16α-Bromoepiandrosterone, an Antimalarial Analogue of the Hormone Dehydroepiandrosterone, Enhances Phagocytosis of Ring Stage Parasitized Erythrocytes: a Novel Mechanism for Antimalarial Activity , 2002, Antimicrobial Agents and Chemotherapy.
[9] C. Rinaldo,et al. Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection , 1995, Clinical and diagnostic laboratory immunology.
[10] L. Pedneault,et al. Intra-Assay Performance Characteristics of Five Assays for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma , 1998, Journal of Clinical Microbiology.
[11] P. Ghys,et al. © Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2004 , 2004 .
[12] John W. Ward,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[13] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[14] S. Krudsood,et al. Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000. , 2007, The American journal of tropical medicine and hygiene.
[15] N. Pedersen,et al. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression. , 2003, Veterinary immunology and immunopathology.
[16] F. Siegal,et al. Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. , 1986, The Journal of clinical investigation.
[17] F. Gheyas,et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.